Early research (Phase 1)Ended earlyNCT05933070
What this trial is testing
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
Who this might be right for
CancerMDS-EBMyelodysplastic Syndromes+2 more
Inmune Bio, Inc. 2